BSEResult2d ago · 27 Oct 2026, 07:04 pm

Financial results for the quarter ended September 30, 2026

SBI Life Insurance Company Ltd · 540719

✦ AI SummaryResults

SBI Life Insurance Company Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, with a surplus of ₹35,270 lakhs and a net commission of ₹1,36,999 lakhs. The company has also approved the appointment of an Independent Director through a postal ballot.

Analysis Scores

Earnings Impact6/10
Growth Catalyst4/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

SBI Life Insurance Company Ltd - 540719 - Financial Results For The Quarter Ended September 30, 2026

Attachments (1)

📄

350a62c0-9a03-4e88-bf24-b41260c8f692.pdf

pdf

Download →
View document text
October 27, 2026 SBIL/CS/NSE-BSE/2627/133 Vice President General Manager Listing Department, Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, BKC, Dalal Street, Bandra (East), Mumbai 400051 Mumbai 400001 NSE Symbol: SBILIFE BSE Scrip Code: 540719 Dear Sir / Madam, Subject: Outcome of Board Meeting held on October 27, 2026 In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2627/119 dated October 15, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the meeting of the Board of Directors of the Company commenced at 03:30 P.M. and concluded at 06:45 P.M. on Tuesday, October 27, 2026 which inter-alia approved the following items: 1. Approval of Unaudited Financial Results Pursuant to Regulation 33 of the Listing Regulations and other applicable requirements, a copy of the Unaudited Financial Results for the quarter and half year ended September 30, 2026 together with the Limited Review Reports in the prescribed format is enclosed. We would like to state that M/s. K S Aiyar & Co., Chartered Accountants and M/s. J Singh & Associates, Chartered Accountants, joint statutory auditors of the Company, have issued Limited Review Reports with unmodified opinion. Further, the trading window to deal in securities of the Company will be re-opened from Friday, October 30, 2026, for all the Designated Persons of the Company. 2. Approval of Postal Ballot notice The Board of Directors has inter alia, agreed that Shareholders’ approval be sought through Postal Ballot for the appointment of Mr. Nihar Niranjan Jambusaria (DIN: 01808733), as an Independent Director of the Company The Notice of Postal Ballot shall be circulated on Tuesday, November 03, 2026 through electronic mode to all Shareholders whose names appear on the Register of Members maintained by National Securities Depository Limited / Central Depository Services (India) Limited/ the Registrar and Share Transfer Agent, as the case may be, as on Friday, October 30, 2026 (Cut-off Date). The e-Voting period will commence from 09:00 A.M. (IST) on Wednesday, November 04, 2026 and shall conclude at 05:00 P.M. (IST) on Thursday, December 03, 2026. Public SBI Life Insurance Company Ltd. Registered and Corporate Office: Natraj, M.V. Road and Western Express Highway Junction Andheri (East), Mumbai 400 069. Tel.: (022) 6191 0000/ 3968 0000 IRDAI Regn. No. 111. CIN: L99999MH2000PLC129113 www.sbilife.co.in The above information is also made available on the Company’s website at www.sbilife.co.in. We request you to kindly take the above information on record. Thanking You, Yours faithfully, Girish Manik Company Secretary ACS No. 26391 Encl: A/a Public SBI Life Insurance Company Ltd. Registered and Corporate Office: Natraj, M.V. Road and Western Express Highway Junction Andheri (East), Mumbai 400 069. Tel.: (022) 6191 0000/ 3968 0000 IRDAI Regn. No. 111. CIN: L99999MH2000PLC129113 www.sbilife.co.in SEARCHABLE FORMAT SBI Life Insurance Company Limited Statement of Unaudited Financial Results for the quarter and half year ended September 30, 2026 (₹ in Lakhs) SI. Particulars Three months ended/ As at Half year ended/ As at Year ended/ As No. September 30, June 30, September 30, September 30, September 30, March 31, 2026 2026 2025 2026 2025 2026 (Unaudited) (Unaudited) (Audited) (Unaudited) (Audited) (Audited) POLICYHOLDERS' A/C 1 Gross premium income (a) First Year Premium 5,75,586 4,95,493 5,28,946 10,71,080 8,82,893 21,84,099 (b) Renewal Premium 15,76,364 12,38,179 14,00,283 28,14,542 24,54,911 58,73,477 (c) Single Premium 5,59,563 3,95,293 5,79,160 9,54,856 9,51,974 20,71,034 2 Net premium income1 26,87,770 20,07,821 24,84,831 46,95,591 42,02,681 99,95,592 3 Income from investments (Net)2 (2,61,383) 25,97,702 (2,05,532) 23,36,319 19,46,982 11,06,211 4 Other income 2,783 3,547 1,623 6,330 850 7,392 5 Transfer of funds from Shareholders' A/c - - - - - 1,87,393 6 Total (2 to 5) 24,29,170 46,09,070 22,80,922 70,38,240 61,50,513 1,12,96,588 7 Commission on (a) First Year Premium 87,455 61,236 79,531 1,48,691 1,30,080 2,80,276 (b) Renewal Premium 41,129 25,151 35,421 66,280 57,808 1,45,226 (c) Single Premium 8,415 6,569 9,079 14,984 14,748 24,069 8 Net Commission1 1,36,999 92,956 1,24,031 2,29,955 2,02,636 4,49,571 9 Operating Expenses related to insurance business (a + b): 1,71,749 1,63,546 1,51,886 3,35,295 2,64,798 6,22,546 (a) Employees remuneration and welfare expenses 89,164 79,863 82,785 1,69,027 1,53,701 3,25,175 (b) Other operating expenses 82,585 83,683 69,101 1,66,268 1,11,097 2,97,371 10 Expenses of Management (8+9) 3,08,747 2,56,502 2,75,917 5,65,249 4,67,434 10,72,117 11 Provisions for doubtful debts (including bad debts written off) 24 10 20 34 49 104 12 Provisions for diminution in value of investments and provision for (26) 4,206 2,971 standard assets & non standard assets 16,442 16,415 790 13 Goods and Service Tax (GST) on charges 52 40 26,774 91 52,883 52,530 14 Provision for taxes 3,614 4,725 1,858 8,340 6,383 15,945 15 Benefits Paid3 (Net)1 15,51,449 13,12,672 13,48,211 28,64,120 23,60,048 54,32,349 16 Change in actuarial liability 5,13,573 29,81,156 6,03,921 34,94,729 31,93,915 43,93,816 17 Total (10+11+12+13+14+15+16) 23,93,900 45,55,079 2 2,60,907 69,48,979 60,83,683 1 ,09,67,651 18 Surplus/(Deficit) (6-17) 35,270 53,991 2 0,015 8 9,261 66,830 3 ,28,937 19 Appropriations (a) Transferred to Shareholders A/c 24,167 45,778 20,572 69,945 52,727 3,16,009 (b) Funds for Future Appropriations 11,103 8,213 ( 557) 19,316 14,103 12,928 20 Details of Surplus/ (Deficit) (a) Interim & terminal bonus paid 23,932 13,433 15,659 37,365 24,645 70,333 (b) Allocation of bonus to policyholders - - - - - 2,06,055 (c) Surplus shown in the Revenue Account 35,270 53,991 20,015 89,261 66,830 3,28,937 Total Surplus 59,202 67,424 35,674 1,26,626 91,475 6,05,325 SHAREHOLDERS' A/C 21 Transfer from Policyholders' Account 24,167 45,778 20,572 69,945 52,727 3,16,009 22 Total income under Shareholders ' Account (a) Investment Income2 35,583 28,155 32,233 63,738 61,519 1,29,743 (b) Other income 21 19 - 40 - - 23 Expenses other than those related to insurance business 1,299 694 1,464 1,992 2,219 2,974 24 Transfer of funds to Policyholders' A/c - - - - - 1,87,393 25 Provisions for doubtful debts (including write off) - - - - - - Provisions for diminution in value of investments and provision for 3,100 (1,329) 23 1,770 (386) 1,645 26 standard assets & non standard assets 27 Profit/ (loss) before tax 55,373 74,588 51,318 1,29,961 1,12,413 2,53,740 28 Provisions for tax 450 2,094 1,859 2,544 3,517 6,710 29 Profit/ (loss) after tax and before Extraordinary Items 54,923 72,494 49,459 1,27,417 1,08,896 2,47,030 30 Extraordinary Items (Net of tax expenses) - - - - - - 31 Profit/ (loss) after tax and Extraordinary Items 54,923 72,494 49,459 1,27,417 1,08,896 2,47,030 32 Dividend per share (`): (a) Interim Dividend - - - - - 2.70 (b) Final Dividend - - - - - - 33 Profit/(Loss) carried to Balance Sheet4 19,10,423 18,55,499 16,71,953 19,10,423 16,71,953 17,83,006 34 Paid up equity share capital 1,00,341 1,00,324 1,00,257 1,00,341 1,00,257 1,00,309 35 Reserve & Surplus (excluding Revaluation Reserve) 19,39,032 18,82,201 16,92,118 19,39,032 16,92,118 18,08,305 36 Fair Value Change Account and Revaluation Reserve (Shareholders) 14,500 29,401 37,265 14,500 37,265 ( 75) 37 Total Assets: (a) Investments: Shareholders ' 18,83,185 18,47,759 16,71,736 18,83,185 16,71,736 16,71,008 Policyholders Fund excluding Linked Assets 2,27,68,339 2,22,19,738 1,98,82,260 2,27,68,339 1,98,82,260 2,10,71,296 Assets held to cover Linked Liabilities 2,79,84,331 2,83,47,942 2,65,18,637 2,79,84,331 2,65,18,637 2,58,94,445 (b) Other Assets (Net of current liabilities and provisions) 4,54,390 1,89,169 2,33,820 4,54,390 2,33,820 5,68,587 1Net of reinsurance 2Net o [Showing first 8,000 characters — download PDF for full document]